| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9852 |
| Human Intestinal Absorption | HIA+ | 0.9920 |
| Caco-2 Permeability | Caco2+ | 0.8427 |
| P-glycoprotein Substrate | Substrate | 0.8358 |
| P-glycoprotein Inhibitor | Inhibitor | 0.9139 |
| Inhibitor | 0.5926 |
| Renal Organic Cation Transporter | Inhibitor | 0.5135 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6635 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7768 |
| CYP450 2D6 Substrate | Substrate | 0.8188 |
| CYP450 3A4 Substrate | Substrate | 0.5876 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8793 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9009 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.7954 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8674 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7954 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5333 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9729 |
| Inhibitor | 0.7319 |
| AMES Toxicity | Non AMES toxic | 0.8613 |
| Carcinogens | Non-carcinogens | 0.8886 |
| Fish Toxicity | High FHMT | 0.7633 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7531 |
| Honey Bee Toxicity | Low HBT | 0.6681 |
| Biodegradation | Not ready biodegradable | 0.9941 |
| Acute Oral Toxicity | III | 0.6733 |
| Carcinogenicity (Three-class) | Non-required | 0.7174 |